{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:01:41Z","timestamp":1773745301300,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["2020C03045"],"award-info":[{"award-number":["2020C03045"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702801"],"award-info":[{"award-number":["81702801"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.taap.2020.115079","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T20:10:48Z","timestamp":1591042248000},"page":"115079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["6-Dithio-2\u2032-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase"],"prefix":"10.1016","volume":"401","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-2126","authenticated-orcid":false,"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.taap.2020.115079_bb0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10637-012-9846-2","article-title":"A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers","volume":"31","author":"Baker","year":"2013","journal-title":"Investig. New Drugs"},{"issue":"5","key":"10.1016\/j.taap.2020.115079_bb0010","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI85339","article-title":"Dual targeting of the thioredoxin and glutathione systems in cancer and HIV","volume":"126","author":"Benhar","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.taap.2020.115079_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.bi.53.070184.001115","article-title":"The molecular-structure of centromeres and telomeres","volume":"53","author":"Blackburn","year":"1984","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2020.115079_bb0020","doi-asserted-by":"crossref","unstructured":"Bommer, U.A., Vine, K.L., Puri, P., Engel, M., Belfiore, L., Fildes, K., et al. (2017). Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun. Signal. 15. https:\/\/doi.org\/10.1186\/s12964-017-0164-3 ARTN 9.","DOI":"10.1186\/s12964-017-0164-3"},{"issue":"6","key":"10.1016\/j.taap.2020.115079_bb0025","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.taap.2020.115079_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0955-0674(99)80043-X","article-title":"Telomerase and the maintenance of chromosome ends","volume":"11","author":"Bryan","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.taap.2020.115079_bb0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2020.115079_bb0040","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2147\/CMAR.S159660","article-title":"A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction","volume":"10","author":"Dai","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.taap.2020.115079_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.taap.2020.115079_bb0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/sj.bjc.6603671","article-title":"Telomere and telomerase in stem cells","volume":"96","author":"Hiyama","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.taap.2020.115079_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/1535-7163.MCT-07-0486","article-title":"2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation","volume":"7","author":"Huber","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"5193","key":"10.1016\/j.taap.2020.115079_bb0060","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.taap.2020.115079_bb0065","first-page":"1528","article-title":"PX-12 inhibits the growth of hepatocelluar carcinoma by inducing S-phase arrest, ROS-dependent apoptosis and enhances 5-FU cytotoxicity","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.taap.2020.115079_bb0070","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1007\/s13277-015-4620-7","article-title":"Upregulation of connexin43 contributes to PX-12-induced oxidative cell death","volume":"37","author":"Li","year":"2016","journal-title":"Tumor Biol."},{"issue":"4","key":"10.1016\/j.taap.2020.115079_bb0075","first-page":"241","article-title":"Incidence and mortality of cutaneous melanoma in China, 2014","volume":"27","author":"Liu","year":"2018","journal-title":"China Cancer"},{"key":"10.1016\/j.taap.2020.115079_bb0080","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/OTT.S192923","article-title":"Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer","volume":"12","author":"Liu","year":"2019","journal-title":"Oncotarg.Ther."},{"issue":"22","key":"10.1016\/j.taap.2020.115079_bb0085","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1656","article-title":"Telomere dysfunction induced foci (TIF) analysis","volume":"5","author":"Mender","year":"2015","journal-title":"Bio. Protoc."},{"issue":"1","key":"10.1016\/j.taap.2020.115079_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-14-0609","article-title":"Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-Thio-2\u2032-Deoxyguanosine","volume":"5","author":"Mender","year":"2015","journal-title":"Cancer Discovery"},{"issue":"8","key":"10.1016\/j.taap.2020.115079_bb0095","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neo.2018.06.002","article-title":"Telomerase-mediated strategy for overcoming non-small cell lung Cancer targeted therapy and chemotherapy resistance","volume":"20","author":"Mender","year":"2018","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.taap.2020.115079_bb0100","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1248\/cpb.c16-00310","article-title":"Efficient Thymidine-Selective DNA Interstrand Photo-activated Crosslinking by the 6-Thioguanine Connected via an Ethylene-Linker to the 2 '-Deoxyribose Unit","volume":"64","author":"Nishioka","year":"2016","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.taap.2020.115079_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/1480-9222-13-3","article-title":"A quantitative PCR method for measuring absolute telomere length","volume":"13","author":"O'Callaghan","year":"2011","journal-title":"Biol. Proc. Online"},{"issue":"3","key":"10.1016\/j.taap.2020.115079_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1248\/cpb.c18-00767","article-title":"Potential anticancer activity of Auranofin","volume":"67","author":"Onodera","year":"2019","journal-title":"Chem.Pharm. Bull. (Tokyo)"},{"issue":"7","key":"10.1016\/j.taap.2020.115079_bb0115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-06-2250","article-title":"A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors","volume":"13","author":"Ramanathan","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.taap.2020.115079_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00280-010-1343-8","article-title":"A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination","volume":"67","author":"Ramanathan","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2020.115079_bb0125","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10637-011-9739-9","article-title":"A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy","volume":"30","author":"Ramanathan","year":"2012","journal-title":"Investig. New Drugs"},{"issue":"6","key":"10.1016\/j.taap.2020.115079_bb0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.freeradbiomed.2009.05.027","article-title":"Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift","volume":"47","author":"Rigobello","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.taap.2020.115079_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/88871","article-title":"Telomere dysfunction and evolution of intestinal carcinoma in mice and humans","volume":"28","author":"Rudolph","year":"2001","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.taap.2020.115079_bb0140","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/2159-8290.CD-16-0062","article-title":"Role of telomeres and telomerase in aging and Cancer","volume":"6","author":"Shay","year":"2016","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.taap.2020.115079_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.mie.2014.11.039","article-title":"Measurement of H2S in vivo and in vitro by the monobromobimane method","volume":"554","author":"Shen","year":"2015","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.taap.2020.115079_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-017-0179-6","article-title":"Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review","volume":"36","author":"Simon","year":"2017","journal-title":"Chinese J. Cancer"},{"issue":"4","key":"10.1016\/j.taap.2020.115079_bb0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/0008-5472.CAN-16-0987","article-title":"The natural Diterpenoid Isoforretin a inhibits Thioredoxin-1 and triggers potent ROS-mediated antitumor effects","volume":"77","author":"Sun","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2020.115079_bb0160","article-title":"New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS\/MS","volume":"7","author":"Tan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.taap.2020.115079_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010073","article-title":"Telomere biology and human phenotype","volume":"8","author":"Turner","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.taap.2020.115079_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-pathol-020712-164030","article-title":"The role of telomere biology in Cancer","volume":"8","author":"Xu","year":"2013","journal-title":"Ann. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2020.115079_bb0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/13543776.2017.1272576","article-title":"Thioredoxin reductase inhibitors: a patent review","volume":"27","author":"Zhang","year":"2017","journal-title":"Exp. Opin.Ther. Patents"},{"issue":"9","key":"10.1016\/j.taap.2020.115079_bb0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","article-title":"Targeting the Thioredoxin system for Cancer therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"19","key":"10.1016\/j.taap.2020.115079_bb0185","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1158\/1078-0432.CCR-17-2773","article-title":"Induction of telomere dysfunction prolongs disease control of therapy-resistant melanoma","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2020.115079_bb0190","first-page":"19","article-title":"Report of cancer epidemiology in China, 2015","volume":"41","author":"Zheng","year":"2019","journal-title":"Chinese J. Oncol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20302039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20302039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:51:45Z","timestamp":1758574305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20302039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S0041008X20302039"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115079","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Dithio-2\u2032-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115079"}}